Irhythm Holdings Inc 's ROA from the second quarter of 2026 to the second quarter of 2025 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics

What is Irhythm Holdings Inc 's ROA in the second quarter of 2026?
Irhythm Holdings Inc recorded a cumulative net loss of $-14 million during 12 months ending in the second quarter of 2026, resulting in a negative return on assets (ROA) of -1.26%.

However, within the Healthcare sector 225 other companies had a higher return on assets. While Return on assets, overall ranking has advanced in the Jun 30 2026 quarter, so far to 2834, from total ROA ranking in the first quarter of 2026 at 3427.

What is ROA?

Select the Comparisons :

None ▼

Select the Ratio:

Return on Assets ROA▼

None ▼

Return on Assets ROA▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

Return On Assets	(Jun 30 2026) II. Quarter	(Mar 31 2026) I. Quarter	(Dec 31 2025) IV. Quarter	(Sep 30 2025) III. Quarter	(Jun 30 2025) II. Quarter
Y / Y Total Assets Change	45.62 %	8.67 %	15.7 %	14.89 %	10.18 %
Y / Y Net Income Change	-	-	-	-	-
Net Income (TTM) in million	-14	-28	-45	-51	-92
Return On Assets (TTM)	-1.26 %	-2.78 %	-4.56 %	-5.46 %	-10.15 %
IRTC's Total Ranking	# 2834	# 3427	# 3056	# 3290	# 3341
Total Assets (TTM) in million	1,404	1,006	1,026	995	964
Seq. Total Assets Change	39.49 %	-1.9 %	3.08 %	3.23 %	4.1 %
Seq. Net Income Change	-	-	-	-	-

IRTC's 5 Years Annual ROA >> Back to IRTC Management Effectiveness >> Compare IRTC ROA to its Competitors

Return On Assets Company Ranking
Within:	No.
Industry	# 71
Sector	# 226
Overall	# 2683

Return On Assets Statistics
High	Average	Low
-1.36 %	-21.02 %	-42.04 %
(Jun 30 2026)		(Dec 31 2018)

News about Irhythm Holdings Inc Return on Assets ROA

iRhythm Technologies Pioneering Cardiac Monitoring in Europe Amid Financial Challenges,

iRhythm Technologies, Inc. (NASDAQ: IRTC), a prominent player in the digital healthcare arena, has recently made strides in its international expansion by launching its Zio cardiac arrhythmia monitoring service across four key European markets: Austria, the Netherlands, Switzerland, and Spain. This launch reflects the growing demand for advanced cardiac monitoring solutions in a rapidly evolving healthcare landscape. However, while the company is enhancing its service offerings, it also faces significant financial hurdles that reveal a complex picture of growth and sustainability. Expansion of Zio Monitoring Service On August 29, 2024, iRhythm Technologies announced the commercial launch of its Zio monitor and Zio long-term continuous ambulatory ECG monitoring service, providing patients in Germany, Austria, the Netherlands, Switzerland, and Spain with up to 14 days of continuous ECG monitoring. This service, coupled with the ZEUS (Zio ECG Utilization Software) system, represents a significant leap forward in cardiac monitoring compared to existing methods such as the traditional 24 to 48-hour Holter monitors. Achieving the European Union s CE Marking under the Medical Device Regulation (EU MDR) in December 2023 is an essential milestone for iRhythm, as it validates the safety and effectiveness of its products in international markets. The expansion is expected to address the demands for cutting-edge cardiac care in Europe, particularly as chronic conditions related to heart health continue to rise.

Financial Statements
Irhythm Holdings Inc 's Assets	$ 1,404 million	IRTC's Balance sheet
Irhythm Holdings Inc 's Income	$ 0 million	Quarterly IRTC's Income Statement
IRTC's Income by Division		See IRTC's Income by Division

Annual Return On Assets	(Dec 31 2025) FY 2025	(Dec 31 2024) FY 2024	(Dec 31 2023) FY 2023	(Dec 31 2022) FY 2022	(Dec 31 2021) FY 2021
Y / Y Total Assets Change	22.93 %	129.83 %	-1.16 %	2.62 %	-11.33 %
Total Assets in million	1,090	887	386	390	380
Y / Y Net Income Change	-	-	-	-	-
Net Income in million	-45	-113	-123	-116	-101
Annual Return On Assets	-4.09 %	-12.78 %	-31.99 %	-29.76 %	-26.65 %

IRTC's 5 Years Annual ROA >> Back to IRTC Management Effectiveness >> Compare IRTC ROA to its Competitors

More Return On Assets Ratios
IRTC's' Return on Assets at Yahoo Finance
Medical Equipment & Supplies Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
IRTC's Roa Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for IRTC's Competitors
Subscribers only: Roa for Irhythm Holdings Inc 's Suppliers
Subscribers only: Return On Assets for IRTC's Customers

You may also want to know
IRTC's Roi	IRTC's Inventory Turnover Ratio	IRTC's Growth Rates	IRTC's Dividend Comparisons
	IRTC's Profitability Ratios	IRTC's Asset Turnover Ratio	IRTC's Dividend Growth
IRTC's Roe	IRTC's Valuation Ratios	IRTC's Financial Strength Ratios	IRTC's Dividend Payout Ratio

Companies with similar Return On Assets at Jun 30 2026, within Healthcare Sector

ROA

Date modified: 2026-09-08T01:19:09+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.